All Digital Industry Symposia
All Digital Industry Symposia
All Digital Symposia will be made available on the PAAM Digital 2021 platform.
Friday, 12 November 2021
Industry Symposium 1
11:30 – 12:45 (CET)
Nutricia: Latest real world data on the CMA journey; how can synbiotics reduce the health burden for infants and their families?
Chair: Rosan Meyer, UK
Infants/young children living with CMA have an increased health burden
Speaker: Kate Grimshaw, UK
Modulating the gut microbiota and improving immune outcomes
Speaker: Rebecca Stratton, UK
Case Studies
Speakers: Maria Eugenia Gervasoni, Argentina; Gemma Castillejo, Spain
Closing & Key messages
Chair: Rosan Meyer, UK
Industry Symposium 2
13:00 – 14:15 (CET)
DBV Technologies: Patients with peanut allergy: emerging solutions for a comprehensive management
Moderators: Montserrat Alvaro Lozano, Spain; Christian Vogelberg, Germany
Introduction: Current status of peanut allergy management in europe
Speaker: Montserrat Alvaro Lozano, Spain
Peanut immunotherapy: to a standardized approach
Speaker: Andre Knulst, The Netherlands
Peanut allergy management in a digital world
Speaker: Stephanie Dramburg, Germany
Conclusion
Speaker: Christian Vogelberg, Germany
Industry Symposium 3
14:30 – 15:45 (CET)
Nestlé Nutrition Institute: The link between early diet and food allergy
Moderator: Liam O’Mahony, Ireland
Introduction
Speaker: Liam O’Mahony, Ireland
Early interventions and long lasting effect on childhood allergies: The GINI study 20y results
Speaker: Monika Gappa, Germany
How do maternal diet and infant complementary feeding influence food allergy
Speaker: Carina Venter, USA
What do existing food allergy prevention studies tell us? What does the future hold?
Speaker: Kari Nadeau, USA
Live Q&A
Speakers: Liam O’Mahony, Ireland; Monika Gappa, Germany; Carina Venter, USA; Kari Nadeau, USA
Industry Symposium 4
16:00 – 17:15 (CET)
Sanofi Genzyme & Regeneron: Childhood asthma and the impact of type 2 inflammation
Opening remarks
Speakers: Leonard Bacharier, USA; Nikolaos Papadopoulos, Greece
The burden of childhood asthma
Speaker: Nikolaos Papadopoulos, Greece
Allergic asthma and type 2 inflammation in childhood
Speaker: Leonard Bacharier, USA
Panel Discussion: Type 2 inflammation in childhood asthma
Speakers: Leonard Bacharier, USA; Nikolaos Papadopoulos, Greece
Audience Q&A
Speakers: Leonard Bacharier, USA; Nikolaos Papadopoulos, Greece
Closing remarks
Speakers: Leonard Bacharier, USA; Nikolaos Papadopoulos, Greece
Saturday, 13 November 2021
Industry Symposium 5
10:00 – 11:15 (CET)
ALK: Raising paediatric awareness through growing evidence for allergy immunotherapy – optimise the treatment of children suffering from respiratory allergy
Introduction and setting the stage for paediatric allergic disease
Speaker: Priya Bansal, USA
Raising awareness of the disease burden in children and the preventive role of allergy immunotherapy
Speaker: Graham Roberts, UK
The growing evidence for SQ SLIT-tablet treatment in children – symptom control and sustained long-term efficacy
Speaker: Douglas Mack, Canada
From childhood to adolescence – providing patient-tailored education
Speaker: Marta Vazquez-Ortiz, UK
Panel discussion
Speakers: Priya Bansal, USA; Graham Roberts, UK; Douglas Mack, Canada; Marta Vazquez-Ortiz, UK
Industry Symposium 6
11:30 – 12:45 (CET)
Aimmune: Treating peanut allergy with oral immunotherapy: new data and practical experience.
Moderator: Jonathan Hourihane, Ireland
Introduction
Speaker: Jonathan Hourihane, Ireland
Key phase 3 clinical data
Speaker: Kirsten Beyer, Germany
Data update
Speaker: Jonathan Hourihane, Ireland
Panel discussion: key learnings from practical experience
Speakers: Jonathan Hourihane, Ireland; Kirsten Beyer, Germany; Janet Beausoleil, USA
Live Q&A session
Speakers: Jonathan Hourihane, Ireland; Kirsten Beyer, Germany; Janet Beausoleil, USA
Industry Symposium 7
16:00 – 17:15 (CET)
Uriach: How can we improve the approach to treating chronic urticaria in children?
Moderator: Montserrat Álvaro, Spain
Introduction
Speaker: Montserrat Álvaro, Spain
Management of pediatric chronic urticaria patients: the gap between guidelines and practice
Speaker: Montserrat Álvaro, Spain
The prevalence and pathogenesis of chronic urticaria in children
Speaker: Stefania Arasi, Italy
The added value of rupatadine in pediatric chronic urticaria
Speaker: Vicky Xepapadaki, Greece
Discussion and Q&A
Speaker: Montserrat Álvaro, Spain